Bivalent inactivated vaccine (Royal Bio-Pharmaceutical)

双价肾综合征出血热灭活疫苗（罗益生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBivalent inactivated vaccine (Royal Bio-Pharmaceutical)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Inactivated vaccine > Whole microorganism inactivated vaccineVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Multivalent vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHemorrhagic Fevers, Viral

Global Approved IndicationsHemorrhagic Fevers, Viral

Approved Indications in ChinaHemorrhagic Fevers, Viral

Original Approved Country/TerritoryMainland China

Original Approved Date2003/12/25

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesRoyal (Wuxi) Bio-Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesRoyal (Wuxi) Bio-Pharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsHemorrhagic Fevers, Viral

Inactive IndicationsN/A

Other Information

ATC CodeJ07BX